Jiri Bartek
- Molecular Biology top 5%
- Oncology top 2%
- Cell Biology top 2%
- Genetics top 10%
- Cancer Research top 10%
- Co-authors
- Jiřina BártkováMike StraussErich A. NiggAndrew M. FryPatrick MeraldiKristian HelinMikkel RohdeJiří Lukáš
- Topics
- Cancer-related Molecular Pathways (12 papers)Ubiquitin and proteasome pathways (4 papers)Microtubule and mitosis dynamics (4 papers)
- Cited by
- OncologyCell BiologyBiotechnology
In The Last Decade
Jiri Bartek
15 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 76
- Molecular Biology 1.5k
- Oncology 1.4k
- Cell Biology 669
- Genetics 262
- Cancer Research 254
Countries citing papers authored by Jiri Bartek
This map shows the geographic impact of Jiri Bartek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiri Bartek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiri Bartek more than expected).
Fields of papers citing papers by Jiri Bartek
This network shows the impact of papers produced by Jiri Bartek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiri Bartek. The network helps show where Jiri Bartek may publish in the future.
Co-authorship network of co-authors of Jiri Bartek
This figure shows the co-authorship network connecting the top 25 collaborators of Jiri Bartek. A scholar is included among the top collaborators of Jiri Bartek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiri Bartek. Jiri Bartek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 31 | |
| 3 | [Initial experience with use of cationic propyl gallate as an inducer of thrombocyte aggregation in evaluation of anti-aggregation therapy]. | 1 |
| 4 | 44 | |
| 5 | 54 | |
| 6 | 15 | |
| 7 | 398 | |
| 8 | p21WAF1/CIP1 mutants deficient in inhibiting cyclin-dependent kinases (CDKs) can promote assembly of active cyclin D/CDK4(6) complexes in human tumor cells. | 28 |
| 9 | 192 | |
| 10 | 106 | |
| 11 | 322 | |
| 12 | 255 | |
| 13 | 4 | |
| 14 | 139 | |
| 15 | 316 | |
| 16 | Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumour cell lines. | 229 |
About Jiri Bartek
Jiri Bartek is a scholar working on Oncology, Cell Biology and Ophthalmology, having authored 16 papers that have together received 2.1k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (12 papers), Ubiquitin and proteasome pathways (4 papers) and Microtubule and mitosis dynamics (4 papers). The work is most often cited by research in Oncology (1.4k citations), Cell Biology (669 citations) and Biotechnology (202 citations). Jiri Bartek has collaborated with scholars based in Denmark, Germany and Sweden. Frequent co-authors include Jiřina Bártková, Mike Strauss, Erich A. Nigg, Andrew M. Fry, Patrick Meraldi, Kristian Helin, Mikkel Rohde, Jiří Lukáš, Birgit Otzen Petersen and Karin Holm. Their work appears in journals such as Nature Medicine, Nature Cell Biology and Molecular and Cellular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.